Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew T Roe

Showing results (141-150 of 467) with videos related to

Pageof 47
Sort By:
American Heart Journal|November 9, 2016
A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart diseaseRobert C Welsh, Matthew T Roe, Philippe Gabriel Steg, et al.
Journal of the American Geriatrics Society|September 17, 2009
Age and persistent use of cardiovascular medication after acute coronary syndrome: results from medication applied and sustained over timeRobin C Ali, Chiara Melloni, Fang-Shu Ou, et al.
Circulation. Cardiovascular Quality and Outcomes|July 20, 2012
Defining heart failure end points in ST-segment elevation myocardial infarction trials: integrating past experiences to chart a path forwardZubin J Eapen, W H Wilson Tang, G Michael Felker, et al.
The Journal of Urology|September 2, 2021
Impact of the COVID-19 Pandemic on Urological Care Delivery in the United StatesDaniel J Lee, Jeremy B Shelton, Paul Brendel, et al.
American Heart Journal|June 25, 2019
Hospital participation in clinical trials for patients with acute myocardial infarction: Results from the National Cardiovascular Data RegistryAlexander C Fanaroff, Amit N Vora, Anita Y Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2010
Independent adjudication of symptomatic heart failure with the use of doxorubicin and cyclophosphamide followed by trastuzumab adjuvant therapy: a combined review of cardiac data from the National Surgical Adjuvant breast and Bowel Project B-31 and the North Central Cancer Treatment Group N9831 clinical trialsStuart D Russell, Kimberly L Blackwell, Julia Lawrence, et al.
International Journal of Cardiology|March 22, 2017
Antithrombotic agents for secondary prevention after acute coronary syndromes: A systematic review and network meta-analysisAlexander C Fanaroff, Vic Hasselblad, Matthew T Roe, et al.
The American Journal of Cardiology|May 29, 2007
Patterns of aspirin dosing in non-ST-elevation acute coronary syndromes in the CRUSADE Quality Improvement InitiativeSumit Tickoo, Matthew T Roe, Eric D Peterson, et al.
The American Journal of Cardiology|September 12, 2016
Trends in Bare-Metal Stent Use in the United States in Patients Aged ≥65 Years (from the CathPCI Registry)Jennifer A Rymer, Robert W Harrison, David Dai, et al.
Circulation. Cardiovascular Quality and Outcomes|October 13, 2011
Use of early clopidogrel by reperfusion strategy among patients presenting with ST-segment elevation myocardial infarctionChiara Melloni, Matthew T Roe, Anita Y Chen, et al.
Pageof 47

Showing results (141-150 of 467) with videos related to

Sort By:
Pageof 47
American Heart Journal|November 9, 2016
A critical reappraisal of aspirin for secondary prevention in patients with ischemic heart diseaseRobert C Welsh, Matthew T Roe, Philippe Gabriel Steg, et al.
Journal of the American Geriatrics Society|September 17, 2009
Age and persistent use of cardiovascular medication after acute coronary syndrome: results from medication applied and sustained over timeRobin C Ali, Chiara Melloni, Fang-Shu Ou, et al.
Circulation. Cardiovascular Quality and Outcomes|July 20, 2012
Defining heart failure end points in ST-segment elevation myocardial infarction trials: integrating past experiences to chart a path forwardZubin J Eapen, W H Wilson Tang, G Michael Felker, et al.
The Journal of Urology|September 2, 2021
Impact of the COVID-19 Pandemic on Urological Care Delivery in the United StatesDaniel J Lee, Jeremy B Shelton, Paul Brendel, et al.
American Heart Journal|June 25, 2019
Hospital participation in clinical trials for patients with acute myocardial infarction: Results from the National Cardiovascular Data RegistryAlexander C Fanaroff, Amit N Vora, Anita Y Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2010
Independent adjudication of symptomatic heart failure with the use of doxorubicin and cyclophosphamide followed by trastuzumab adjuvant therapy: a combined review of cardiac data from the National Surgical Adjuvant breast and Bowel Project B-31 and the North Central Cancer Treatment Group N9831 clinical trialsStuart D Russell, Kimberly L Blackwell, Julia Lawrence, et al.
International Journal of Cardiology|March 22, 2017
Antithrombotic agents for secondary prevention after acute coronary syndromes: A systematic review and network meta-analysisAlexander C Fanaroff, Vic Hasselblad, Matthew T Roe, et al.
The American Journal of Cardiology|May 29, 2007
Patterns of aspirin dosing in non-ST-elevation acute coronary syndromes in the CRUSADE Quality Improvement InitiativeSumit Tickoo, Matthew T Roe, Eric D Peterson, et al.
The American Journal of Cardiology|September 12, 2016
Trends in Bare-Metal Stent Use in the United States in Patients Aged ≥65 Years (from the CathPCI Registry)Jennifer A Rymer, Robert W Harrison, David Dai, et al.
Circulation. Cardiovascular Quality and Outcomes|October 13, 2011
Use of early clopidogrel by reperfusion strategy among patients presenting with ST-segment elevation myocardial infarctionChiara Melloni, Matthew T Roe, Anita Y Chen, et al.
Pageof 47